CATH:LSE:LSE-Lyxor Index Fund - Lyxor MSCI World Catholic Principles ESG (DR) UCITS ETF USD (USD)

ETF | Others |

Last Closing

USD 34.265

Change

+0.16 (+0.46)%

Market Cap

USD 0.11B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+4.25 (+2.21%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-0.04 (-0.03%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.12 (-0.65%)

USD 547.46B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.12 (-0.89%)

USD 547.46B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.70 (-0.97%)

USD 266.08B
0QZO:LSE 0QZO

+0.50 (+0.54%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-1.81 (-1.07%)

USD 202.26B
PRJU:LSE Amundi Index Solutions - Amund..

-0.20 (-0.64%)

USD 200.79B
0R24:LSE Intel Corp.

+0.65 (+2.93%)

USD 196.14B

ETFs Containing CATH:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.66% 88% B+ 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.66% 87% B+ 81% B-
Trailing 12 Months  
Capital Gain 37.82% 92% A 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.82% 91% A- 86% B+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 13.10% 77% C+ 77% C+
Dividend Return 13.10% 76% C+ 76% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.51% 55% F 71% C-
Risk Adjusted Return 104.76% 97% N/A 98% N/A
Market Capitalization 0.11B 51% F 29% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike